Literature DB >> 17154504

Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity.

Marcin Kołaczkowski1, Mateusz Nowak, Maciej Pawłowski, Andrzej J Bojarski.   

Abstract

A set of 31 diversified 5-HT7 receptor antagonists was automatically docked to a conformational ensemble of rhodopsin-based 5-HT7R models (flexible docking). It was found that ergolines, aporphines, and tricyclic psychotropic agents were always docked in a pocket formed by TMHs 4-6, and besides the main ionic bond with Asp3.32, they had specific interactions with Phe6.52, Phe6.51, Trp6.48, and Ser5.42. The arylpiperidine, arylpiperazine, or beta-carboline fragment of the complex ligands occupied the same pocket, whereas the terminal amide/imide part of those compounds reached the second cavity formed by TMHs 7-3 and interacted with Phe3.28, Arg7.36, and Tyr7.43. A similar orientation of selective antagonists of the group of arylsulfonamidoalkylamines was observed, that is, the sulfonamide part was located in the second pocket. Coherent docking results allowed the generation of two receptor-based pharmacophores: first containing features necessary for high 5-HT7R affinity and the other defining selectivity for this receptor subtype. The latter model indicated the importance of specific interactions with the residues of the TMHs 7-3 pocket (especially nonconserved Arg7.36) for selectivity over other monoamine GPCRs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17154504     DOI: 10.1021/jm060300c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia.

Authors:  Monika Marcinkowska; Adam Bucki; Joanna Sniecikowska; Agnieszka Zagórska; Nikola Fajkis-Zajączkowska; Agata Siwek; Monika Gluch-Lutwin; Paweł Żmudzki; Magdalena Jastrzebska-Wiesek; Anna Partyka; Anna Wesołowska; Michał Abram; Katarzyna Przejczowska-Pomierny; Agnieszka Cios; Elżbieta Wyska; Kamil Mika; Magdalena Kotańska; Paweł Mierzejewski; Marcin Kolaczkowski
Journal:  J Med Chem       Date:  2021-08-26       Impact factor: 7.446

Review 3.  Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.

Authors:  Andrea Rague; Kevin Tidgewell
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

4.  Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.

Authors:  Agata Antonina Rita Impellizzeri; Matteo Pappalardo; Livia Basile; Ornella Manfra; Kjetil Wessel Andressen; Kurt Allen Krobert; Angela Messina; Finn Olav Levy; Salvatore Guccione
Journal:  Front Behav Neurosci       Date:  2015-05-08       Impact factor: 3.558

5.  A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network.

Authors:  Xiaoqian Huo; Fang Lu; Liansheng Qiao; Gongyu Li; Yanling Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-28       Impact factor: 2.629

6.  Solvates of New Arylpiperazine Salicylamide Derivative-a Multi-Technique Approach to the Description of 5 HTR Ligand Structure and Interactions.

Authors:  Edyta Pindelska; Anna Marczewska-Rak; Jolanta Jaśkowska; Izabela D Madura
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.